Sweden Genome Editing Market Size & Outlook, 2026-2033
The genome editing market in Sweden is expected to reach a projected revenue of US$ 518.9 million by 2033. A compound annual growth rate of 16.3% is expected of Sweden genome editing market from 2026 to 2033.
Revenue, 2025 (US$M)
$155.9
Forecast, 2033 (US$M)
$518.9
CAGR, 2026 - 2033
16.3%
Report Coverage
Sweden
Related Markets
Sweden genome editing market highlights
- The Sweden genome editing market generated a revenue of USD 155.9 million in 2025 and is expected to reach USD 518.9 million by 2033.
- The Sweden market is expected to grow at a CAGR of 16.3% from 2026 to 2033.
- In terms of segment, crispr/cas9 was the largest revenue generating technology in 2025.
- CRISPR/Cas9 is the most lucrative technology segment registering the fastest growth during the forecast period.
Genome editing market data book summary
| Market revenue in 2025 | USD 155.9 million |
| Market revenue in 2033 | USD 518.9 million |
| Growth rate | 16.3% (CAGR from 2026 to 2033) |
| Largest segment | Crispr/cas9 |
| Fastest growing segment | CRISPR/Cas9 |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CRISPR/Cas9, TALENs/MegaTALs, ZFN, Meganuclease |
| Key market players worldwide | Merck KGaA, Cibus Inc Ordinary Shares - Class A, Recombinetics, Sangamo Therapeutics Inc, Editas Medicine Inc, Precision BioSciences Inc, CRISPR Therapeutics AG, Intellia Therapeutics Inc, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, AstraZeneca PLC, Takara Bio Inc, Horizon Discovery, Danaher Corp, Genscript Biotech Corp Class H, New England Biolabs, Origene Technologies, Bluebird bio Inc, Lonza Group Ltd, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, Sweden accounted for 1.4% of the global genome editing market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, UK genome editing market is projected to lead the regional market in terms of revenue in 2033.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 2,793.8 million by 2033.
Crispr/cas9 was the largest segment with a revenue share of 57.99% in 2025. Horizon Databook has segmented the Sweden genome editing market based on crispr/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2021 to 2033.
In Sweden, increased usage of genome editing in clinical practice for diagnosis and therapeutics development is anticipated to drive market growth. Sweden's genome editing market thrives due to its robust scientific infrastructure, supportive regulatory framework, and emphasis on sustainability & healthcare excellence.
With a focus on personalized medicine, there is a growing demand for advanced genetic tools. Collaboration among academia, industry, and government fuels innovation, aided by skilled workforce and venture capital.
Public-private partnerships and initiatives attract foreign investment. This collaboration is likely to propel Sweden to the forefront of genome editing, driving scientific advancement and economic growth.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genome Editing Market Scope
Genome editing market segmentation & scope
Others
Genome Editing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Precision BioSciences Inc | View profile | 109 | 302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, United States, 27701 | https://www.precisionbiosciences.com |
| Recombinetics | View profile | 11-50 | Eagan, Minnesota, United States, North America | https://recombinetics.com/ |
| Origene Technologies | View profile | 501-1000 | Rockville, Maryland, United States, North America | http://www.origene.com |
| Sangamo Therapeutics Inc | View profile | 405 | 501 Canal Boulevard, Richmond, CA, United States, 94804 | https://www.sangamo.com |
| Bluebird bio Inc | View profile | 323 | 455 Grand Union Boulevard, Somerville, MA, United States, 02145 | https://www.bluebirdbio.com |
| Horizon Discovery | View profile | 101-250 | Cambridge, Cambridgeshire, United Kingdom, Europe | http://www.horizondiscovery.com |
| Cibus Inc Ordinary Shares - Class A | View profile | 183 | 6455 Nancy Ridge Drive, San Diego, CA, United States, 92121 | https://www.cibus.com |
| Intellia Therapeutics Inc | View profile | 598 | 40 Erie Street, Suite 130, Cambridge, MA, United States, 02139 | https://www.intelliatx.com |
| Editas Medicine Inc | View profile | 226 | 11 Hurley Street, Cambridge, MA, United States, 02141 | https://www.editasmedicine.com |
| CRISPR Therapeutics AG | View profile | 407 | Baarerstrasse 14, Zug, Switzerland, CH-6300 | https://www.crisprtx.com |
| Cellectis SA | View profile | 216 | 8, rue de la Croix Jarry, Paris, France, 75013 | https://www.cellectis.com |
| New England Biolabs | View profile | 501-1000 | Ipswich, Massachusetts, United States, North America | http://neb.com |
| Genscript Biotech Corp Class H | View profile | 6937 | No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, China, People's Republic of, 211100 | https://www.genscript.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Caribou Biosciences Inc Ordinary Shares | View profile | 137 | 2929 7th Street, Suite 105, Berkeley, CA, United States, 94710 | https://www.cariboubio.com |
| Takara Bio Inc | View profile | 1793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | http://www.takara-bio.co.jp |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Sweden genome editing market size, by technology, 2021-2033 (US$M)
Sweden Genome Editing Market Outlook Share, 2025 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
